ATI RN
ATI RN Pharmacology Online Practice 2023 B Questions
Question 1 of 5
A busy patient with many responsibilities is to have a medication ordered to treat her hypertension. To increase compliance with drug therapy, what drug would be a good choice for this patient?
Correct Answer: D
Rationale: Metoprolol would be the best choice because it has an extended-release form that only needs to be taken once a day, which should increase patient compliance. Acebutolol, atenolol, and bisoprolol do not come in extended-release forms. The nurse should consider the patient’s lifestyle and preferences when selecting antihypertensive medications to improve adherence.
Question 2 of 5
Name a desired outcome of the drug Phenytoin:
Correct Answer: C
Rationale: Phenytoin is an anti-seizure medication commonly used to treat and prevent seizures in individuals with epilepsy. The desired outcome of taking Phenytoin is to decrease or completely stop seizures without causing excessive sedation. It works by stabilizing electrical activity in the brain to prevent abnormal firing of neurons that can lead to seizures. Therefore, the main goal of using Phenytoin is to control seizure activity and improve the quality of life for individuals with epilepsy.
Question 3 of 5
A patient asks the nurse for information about fat-soluble vitamins. What is the nurse's best response?
Correct Answer: C
Rationale: Fat-soluble vitamins (A, D, E, K) are stored in the liver and adipose tissue and excreted slowly, making them more likely to accumulate and cause toxicity if taken in excess. They are not metabolized rapidly (A) and can be stored in the liver (B). They can be toxic (D) if consumed in large amounts.
Question 4 of 5
The most common dose-limiting toxicity of chemotherapy is:
Correct Answer: C
Rationale: Myelosuppression, the suppression of bone marrow activity, is the most common dose-limiting toxicity of chemotherapy. It leads to reduced production of blood cells, including white blood cells, red blood cells, and platelets, increasing the risk of infections, anemia, and bleeding. While nausea, vomiting, and mucositis are significant side effects, they can often be managed with supportive care. Myelosuppression, however, can be life-threatening and frequently requires dose adjustments or delays in treatment. Bloody stools are less common and typically not the primary dose-limiting factor.
Question 5 of 5
A 15-year-old female presents to her primary care physician complaining of runny nose and itchy eyes. She said that she first had these symptoms during the spring a few years ago, but each year, they have been bothering her more. You know there are multiple ways to interfere with the signaling that is causing her symptoms. Which of the following drugs would prevent the release of the main chemical mediator in her case?
Correct Answer: A
Rationale: The patient's symptoms-runny nose and itchy eyes during spring-suggest seasonal allergic rhinitis, where histamine is the main chemical mediator released from mast cells. Cromolyn sodium stabilizes mast cells, preventing histamine release, making it a prophylactic agent ideal for this scenario. Diphenhydramine is an H1 antihistamine that blocks histamine receptors after release, not preventing its release, so it's incorrect. Ranitidine is an H2 blocker, affecting gastric acid secretion, not allergic histamine pathways. Loratadine is another H1 antihistamine, also acting post-release. Theophylline (E) is a bronchodilator, irrelevant here. The question emphasizes preventing release, not blocking effects, so Cromolyn sodium stands out. Its mechanism directly addresses the root cause by stabilizing mast cells before allergen exposure triggers histamine release, offering a preventative rather than symptomatic approach, which aligns with the patient's recurring seasonal issue.